ALK — Alkaloid AD Skopje Share Price
Last trade - 00:00- MKD30.98bn
- MKD32.84bn
- MKD16.51bn
- 73
- 33
- 83
- 71
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.68 | ||
| PEG Ratio (f) | 4.3 | ||
| EPS Growth (f) | 4.03% | ||
| Dividend Yield (f) | 2.79% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.24 | ||
| Price to Tang. Book | 2.66 | ||
| Price to Free Cashflow | 48.2 | ||
| Price to Sales | 1.76 | ||
| EV to EBITDA | 11.69 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 12.45% | ||
| Return on Equity | 12.34% | ||
| Operating Margin | 10.52% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | MKDm | 11,102.81 | 12,132.33 | 12,794.18 | 14,289.05 | 16,512.98 | 17,994 | 19,134 | 11.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +17.85 | +15.5 | +12.05 | +12.14 | +7.75 | +18.9 | -1.65 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Alkaloid AD Skopje is a Macedonia-based company active in the pharmaceutical sector. It is engaged in the manufacturing and distribution of pharmaceuticals, the processing of herbal materials and the production of cosmetics, tea, chemical products and coating agents. It operates through two divisions: Pharmaceuticals, and Chemicals, Cosmetics and Botanicals. The Company’s product range includes human drugs, x-ray films, haemodialysis solutions, pharmaceutical raw materials, animal health products, perfumes, household cosmetics, skin, teeth and hair care products, tea and alimentary products. It also operates a development institute for analysis, research and quality control, warehouses and laboratories. The Company operates more than 13 subsidiaries in such countries as Croatia, Serbia, Slovenia, Bosnia and Herzegovina, Bulgaria, Kosovo, the Untied States, Montenegro and the Russian Federation.
Directors
- Miodrag Micajkov CSU (74)
- Zivko Mukaetov CMG (44)
- Viktor Stojcevski CFO (43)
- Oliver Lazareski CEX
- Gjorgji Jovanov COO (54)
- Dejan Krzhovski CIN
- Nikola Dimovski CIO
- Nikola Kolevski CCO
- Natasa Nikolvska VBD
- Dushko Markovski DMK
- Snezana Petrovska DMK
- Nikola Eftimov DHR
- Hristina Babunovska OTH
- Sandra Chomovska Madevska OTH
- Ljube Danilovski OTH
- Elefterija Davceva OTH
- Ernest Debreshlioski OTH
- Dimitar Georgievski OTH
- Filip Godzo OTH
- Ivan Ilevski OTH
- Vladimir Indov OTH
- Tatjana Ivanoska Filipovska OTH
- Danilo Jovanovic OTH
- Emira Kjura (Fida) OTH
- Zoran Kostovski OTH
- Ilija Kovacevski OTH
- Biljana Lazareska OTH
- Jelena Lazova OTH
- Marija Malova OTH
- Emil Micajkov OTH
- Nikola Mizo OTH
- Darko Nanov OTH
- Natasa Nasteva OTH
- Kalina Naumovska OTH
- Maja Nojkova Belevska OTH
- Olivera Paneva OTH
- Nada Popstefanova OTH
- Milos Radulovic OTH
- Nikola Ristov OTH
- Dobrila Sekulovska-Popovska OTH
- Maja Stefkova OTH
- Biljana Taneva OTH
- Ognen Trajkovski OTH
- Sonja Ugarkovic OTH
- Aleksandar Velevska (Hristovski) OTH
- Slobodan Vukajlovic OTH
- Milkica Gligorova MGB (59)
- Kire Icev MGB (44)
- Ilija Djonov SUB (74)
- Bojancho Kralevski SUB (67)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- December 31st, 1990
- Public Since
- January 1st, 1996
- No. of Employees
- 2,843
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Macedonian Stock Exchange
- Shares in Issue
- 1,408,796
- Address
- Aleksandar Makedonski 12, G. Baba, SKOPJE, 1000
- Web
- https://alkaloid.com.mk/
- Phone
- +389 23104000
- Auditors
- PricewaterhouseCoopers Audit
Upcoming Events for ALK
Similar to ALK
Replek AD Skopje
Macedonian Stock Exchange
FAQ
As of Today at 19:11 UTC, shares in Alkaloid AD Skopje are trading at MKD21,993.00. This share price information is delayed by 15 minutes.
Shares in Alkaloid AD Skopje last closed at MKD21,993.00 and the price had moved by +26.76% over the past 365 days. In terms of relative price strength the Alkaloid AD Skopje share price has outperformed the FTSE Global All Cap Index by +13.72% over the past year.
The overall consensus recommendation for Alkaloid AD Skopje is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Alkaloid AD Skopje dividend yield is 2.46% based on the trailing twelve month period.
Last year, Alkaloid AD Skopje paid a total dividend of MKD540.00, and it currently has a trailing dividend yield of 2.46%. We do not have any data on when Alkaloid AD Skopje is to next pay dividends.
We do not have data on when Alkaloid AD Skopje is to next pay dividends. The historic dividend yield on Alkaloid AD Skopje shares is currently 2.46%.
To buy shares in Alkaloid AD Skopje you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of MKD21,993.00, shares in Alkaloid AD Skopje had a market capitalisation of MKD30.98bn.
Here are the trading details for Alkaloid AD Skopje:
- Country of listing: Macedonia
- Exchange: MKE
- Ticker Symbol: ALK
Based on an overall assessment of its quality, value and momentum Alkaloid AD Skopje is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Alkaloid AD Skopje is MKD18,763.00. That is 14.69% below the last closing price of MKD21,993.00.
Analysts covering Alkaloid AD Skopje currently have a consensus Earnings Per Share (EPS) forecast of MKD1,334.00 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alkaloid AD Skopje. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +9.14%.
As of the last closing price of MKD21,993.00, shares in Alkaloid AD Skopje were trading +8.88% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Alkaloid AD Skopje PE ratio based on its reported earnings over the past 12 months is 16.68. The shares last closed at MKD21,993.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Alkaloid AD Skopje's management team is headed by:
- Miodrag Micajkov - CSU
- Zivko Mukaetov - CMG
- Viktor Stojcevski - CFO
- Oliver Lazareski - CEX
- Gjorgji Jovanov - COO
- Dejan Krzhovski - CIN
- Nikola Dimovski - CIO
- Nikola Kolevski - CCO
- Natasa Nikolvska - VBD
- Dushko Markovski - DMK
- Snezana Petrovska - DMK
- Nikola Eftimov - DHR
- Hristina Babunovska - OTH
- Sandra Chomovska Madevska - OTH
- Ljube Danilovski - OTH
- Elefterija Davceva - OTH
- Ernest Debreshlioski - OTH
- Dimitar Georgievski - OTH
- Filip Godzo - OTH
- Ivan Ilevski - OTH
- Vladimir Indov - OTH
- Tatjana Ivanoska Filipovska - OTH
- Danilo Jovanovic - OTH
- Emira Kjura (Fida) - OTH
- Zoran Kostovski - OTH
- Ilija Kovacevski - OTH
- Biljana Lazareska - OTH
- Jelena Lazova - OTH
- Marija Malova - OTH
- Emil Micajkov - OTH
- Nikola Mizo - OTH
- Darko Nanov - OTH
- Natasa Nasteva - OTH
- Kalina Naumovska - OTH
- Maja Nojkova Belevska - OTH
- Olivera Paneva - OTH
- Nada Popstefanova - OTH
- Milos Radulovic - OTH
- Nikola Ristov - OTH
- Dobrila Sekulovska-Popovska - OTH
- Maja Stefkova - OTH
- Biljana Taneva - OTH
- Ognen Trajkovski - OTH
- Sonja Ugarkovic - OTH
- Aleksandar Velevska (Hristovski) - OTH
- Slobodan Vukajlovic - OTH
- Milkica Gligorova - MGB
- Kire Icev - MGB
- Ilija Djonov - SUB
- Bojancho Kralevski - SUB